Charuka Wickramasinghe

Dr. Charuka Wickramasinghe

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2024 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
JLJing Li
Jing Li
Charuka WickramasingheCharuka Wickramasinghe
Charuka Wickramasinghe
JJJun Jiang
Jun Jiang
AWAndrew Wu
Andrew Wu
YJYuanyuan Jiang
Yuanyuan Jiang
NSNader Sanai
Nader Sanai

4 April 2025 in CPT: Pharmacometrics & Systems Pharmacology
Verified
Journal Article
Open access
Charuka WickramasingheCharuka Wickramasinghe
Charuka Wickramasinghe
Seongho KimSeongho Kim
Seongho Kim
JLJing Li
Jing Li
Quantitative understanding of drug penetration and exposure in the human central nervous system (CNS) and brain tumors is essential for the rational development of new drugs and optimal use of existing drugs for brain cancer. To address this need, we developed and validated a novel 9‐compartment permeability‐limited CNS (9‐CNS) physiologically based pharmacokinetic (PBPK) model, enabling mechanistic and quantitative prediction of spatial pharmacokinetics for systemically administered small‐molecule drugs across different regions of the human brain, cerebrospinal fluid, and brain tumors. To make the 9‐CNS model accessible to a broad range of users, we developed the SpatialCNS‐PBPK app, a user‐friendly, web‐based R/Shiny platform built with R and Shiny programming. The app provides key functionalities for model simulation, sensitivity analysis, and pharmacokinetic parameter calculation. This tutorial introduces the development and evaluation of the SpatialCNS‐PBPK app, highlights its key features and functions, and provides a step‐by‐step user guide for practical applications. By enhancing our ability to predict the spatial pharmacokinetics of anticancer drugs in the human CNS and brain tumors, the SpatialCNS‐PBPK app serves as an invaluable computational tool and data‐driven approach for advancing drug development and optimizing treatment strategies for more effective treatment of brain cancer.

7 April 2025 in Numerical Algorithms
Verified
Journal Article
Closed access
PDF file
HLHengguang Li
Hengguang Li
Charuka WickramasingheCharuka Wickramasinghe
Charuka Wickramasinghe
PYPeimeng Yin
Peimeng Yin

30 November 2024 in Communications in Mathematics and Applications
Verified
Journal Article
Open access
PDF file
Charuka WickramasingheCharuka Wickramasinghe
Charuka Wickramasinghe
This paper presents a numerical approach for decoupling singularly perturbed boundary value problems involving fourth-order ordinary differential equations, characterized by a small positive parameter ϵ multiplying the highest derivative. Such equations arise in various engineering and physics applications, including the modeling of diffusing chemical species, viscous flows with convection and diffusion, and heat transfer in electronic chips or microfluidic channels. We focus on problems with Lidstone boundary conditions and demonstrate how the fourth-order equation can be decomposed into a system of two second-order problems—one independent of \(\varepsilon\), and the other singularly perturbed with ϵ multiplying the highest derivative. These problems often exhibit boundary layers, where the solution undergoes rapid changes near the domain boundaries. Numerical solutions to such higher-order problems are typically more challenging than those for lower-order ones. To address this, we propose a linear finite element method combined with a Shishkin mesh to accurately resolve boundary layers. We prove that the solution obtained from the decoupled second-order system is equivalent to that of the original fourth-order problem. The proposed method is direct and highly accurate, with computational time increasing linearly with the number of grid points.


16 November 2026
Verified
Other
Open access
AWAndrew Wu
Andrew Wu
Charuka WickramasingheCharuka Wickramasinghe
Charuka Wickramasinghe
YJYuanyuan Jiang
Yuanyuan Jiang
XBXun Bao
Xun Bao
JLJing Li
Jing Li
Supplementary Figure S1 Population mean plasma concentration – time profiles of the four model drugs following their respective standard dosing regimens (as shown in Table 1). Profiles were simulated in a typical individual (body weight of 70-kg and body surface area of 1.8 m2) using the published population pharmacokinetic parameters in cancer patients (as summarized in Table 1).